The Technical Analyst
Select Language :
Ultragenyx Pharmaceutical [RARE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Ultragenyx Pharmaceutical Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Ultragenyx Pharmaceutical is listed at the  Exchange

2.99% $46.82

America/New_York / 27 mar 2024 @ 16:00


Ultragenyx Pharmaceutical: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 3 854.96 mill
EPS: -8.25
P/E: -5.68
Earnings Date: May 01, 2024
SharesOutstanding: 82.34 mill
Avg Daily Volume: 0.770 mill
RATING 2024-03-27
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Strong Sell
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -5.68 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.97x
Company: PE -5.68 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 44.81 - 48.83

( +/- 4.29%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-11 Kassberg Thomas Richard Sell 11 509 Common Stock
2024-03-07 Fust Matthew K Sell 2 550 Common Stock
2024-03-07 Fust Matthew K Sell 2 145 Common Stock
2024-03-07 Fust Matthew K Sell 7 500 Common Stock
2024-03-01 Horn Howard Buy 19 400 Common Stock
INSIDER POWER
45.78
Last 99 transactions
Buy: 937 632 | Sell: 375 059

Forecast: 16:00 - $46.85

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $46.85
Forecast 2: 16:00 - $46.85
Forecast 3: 16:00 - $46.85
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $46.82 (2.99% )
Volume 0.521 mill
Avg. Vol. 0.770 mill
% of Avg. Vol 67.64 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Ultragenyx Pharmaceutical Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Ultragenyx Pharmaceutical Inc

RSI

Intraday RSI14 chart for Ultragenyx Pharmaceutical Inc

Last 10 Buy & Sell Signals For RARE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:34sell$45.30N/AActive
Profile picture for
            Ultragenyx Pharmaceutical Inc

RARE

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc., Solid Biosciences Inc.; and Daiichi Sankyo Co., Ltd. Ultragenyx Pharmaceutical Inc. was incorporated in 2010 and is headquartered in Novato, California.

Last 10 Buy Signals

Date Signal @
FRONTUSDMar 28 - 08:37$1.261
ETHUPUSDMar 28 - 08:3834.73
XTZUSDMar 28 - 08:37$1.381
XAUTUSDMar 28 - 08:35$2 208.64
GASUSDMar 28 - 08:34$6.97
AAVEUSDMar 28 - 08:36$124.81
MASKUSDMar 28 - 08:35$5.22
GHSTUSDMar 28 - 08:35$1.632
GAFIUSDMar 28 - 08:349.30
KWENTAUSDMar 28 - 08:34110.22

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.